(Q46591573)

English

Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial

scientific article published on 19 May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

1 reference

based on heuristic

inferred from title

generalized anxiety disorder

1 reference

based on heuristic

inferred from title

Humberto Nicolini

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

author name string

D Bakish

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

H Duenas

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

M Spann

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

J Erickson

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

C Hallberg

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

S Ball

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

D Sagman

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

J M Russell

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

language of work or name

0 references

publication date

19 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

Psychological Medicine

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

39

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

267-276

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

Experience and appraisal of worry among high worriers with and without generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

Symptomatic volunteers in multicenter drug trials

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

An overview of generalized anxiety disorder: disease state--appropriate therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

The Rater Applied Performance Scale: development and reliability

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

Content of Worry in the Community

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

21 January 2018

Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ER.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A)

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708003401

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0033291708003401

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18485261

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46591573&oldid=2121195452"